Cck2r Antagonists - Cancer Science

Relevant Publications

CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery.

Issue Release: 2024

Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations.

Issue Release: 2023

Elevated Serum Gastrin Is Associated with Melanoma Progression: Putative Role in Increased Migration and Invasion of Melanoma Cells.

Issue Release: 2023

The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.

Issue Release: 2021

Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention.

Issue Release: 2019

Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.

Issue Release: 2015

Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.

Issue Release: 2014

Up-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemia.

Issue Release: 2014

Cholecystokinin octapeptide regulates the differentiation and effector cytokine production of CD4(+) T cells in vitro.

Issue Release: 2014

Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.

Issue Release: 2013

Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.

Issue Release: 2012

Gastrin receptor pharmacology.

Issue Release: 2012

Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.

Issue Release: 2010

Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.

Issue Release: 2009

Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.

Issue Release: 2007

Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Issue Release: 2007

Strategies for design of non peptide CCK1R agonist/antagonist ligands.

Issue Release: 2007

Effects of cholecystokinin-receptor antagonists on Fos-like immunoreactivity stimulated by sulfated cholecystokinin-8 in neurons of the myenteric plexus and hindbrain of rats.

Issue Release: 2005

Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptors.

Issue Release: 2005

Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.

Issue Release: 2004

How can funding agencies support collaboration?

What is the importance of a multidisciplinary team in cancer treatment?

How is Euclidean Distance Used in Cancer Research?

How Common is PTSD Among Cancer Patients?

What is Dose Modulation?

Who is Accountable?

How Are Pre-Treatment Medications Determined?

What are Some Successful Examples of Cancer Collaboration?

When Should You Contact Your Healthcare Provider?

What Are the Key Initiatives by Public Health Authorities to Improve Cancer Care?

Cck2r Antagonists - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics